Paul Armistead, MD, PhD
Paul Armistead first came to UNC-Chapel Hill as part of the highly-selective Morehead-Cain Scholars program and majored in Chemistry. Thanks to UCRF support, he has returned to North Carolina to help advance the state’s cancer research agenda.
Armistead continued his education in the MD-PhD program at the UNC School of Medicine. He completed his residency in internal medicine at Brigham and Women’s Hospital in Boston, Massachusetts. He went on to do a fellowship in hematology and oncology and an instructorship in stem cell transplantation at the University of Texas MD Anderson Cancer Center in Houston. His work at UNC focuses on identifying and testing agents to help the immune system fight leukemia.